[
  {
    "ts": null,
    "headline": "Vertex Provides Pipeline and Business Updates in Advance of Upcoming Investor Meetings",
    "summary": "BOSTON, January 12, 2025--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced multiple program updates ahead of upcoming investor meetings in January, including the company’s scheduled webcast from the 43rd Annual J.P. Morgan Healthcare Conference on Monday, January 13, 2025, at 10:30 a.m. ET/7:30 a.m. PT.",
    "url": "https://finnhub.io/api/news?id=0e455d49e1926bbc2991c0bf7743f99a7824e01a4f2151360cd4e74eff3af0d3",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736719260,
      "headline": "Vertex Provides Pipeline and Business Updates in Advance of Upcoming Investor Meetings",
      "id": 132421527,
      "image": "https://media.zenfs.com/en/business-wire.com/975c96962d0c8cecec94e5083a3e35e9",
      "related": "VRTX",
      "source": "Yahoo",
      "summary": "BOSTON, January 12, 2025--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced multiple program updates ahead of upcoming investor meetings in January, including the company’s scheduled webcast from the 43rd Annual J.P. Morgan Healthcare Conference on Monday, January 13, 2025, at 10:30 a.m. ET/7:30 a.m. PT.",
      "url": "https://finnhub.io/api/news?id=0e455d49e1926bbc2991c0bf7743f99a7824e01a4f2151360cd4e74eff3af0d3"
    }
  }
]